Comparative efficacy and safety of glucose‐lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative efficacy and safety of glucose‐lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta‐analysis

Published:2021-01-06 Issue:3 Volume:23 Page:822-831
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Avgerinos Ioannis¹²^ORCID,Manolopoulos Apostolos¹^ORCID,Michailidis Theodoros¹²^ORCID,Kitsios Konstantinos¹²,Liakos Aris¹²^ORCID,Karagiannis Thomas¹²^ORCID,Dimitrakopoulos Konstantinos¹²,Matthews David R.³⁴^ORCID,Tsapas Apostolos¹²³^ORCID,Bekiari Eleni¹²^ORCID

Affiliation:

1. Clinical Research and Evidence‐Based Medicine Unit, Second Medical Department Aristotle University of Thessaloniki Thessaloniki Greece

2. Diabetes Centre, Second Medical Department Aristotle University of Thessaloniki Thessaloniki Greece

3. Harris Manchester College University of Oxford Oxford UK

4. Oxford Centre for Diabetes, Endocrinology and Metabolism Churchill Hospital Oxford UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14291

Reference43 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

2. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

3. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

4. Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus

5. Systematic literature review and network meta‐analysis of sodium‐glucose co‐transporter inhibitors vs metformin as add‐on to insulin in type 1 diabetes

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of glucose-lowering drugs as an adjunct to insulin therapy in Chinese patients with type 1 diabetes: a retrospective, observational study;Endocrine;2024-09-09

2. Analysis on the contribution of glucagon receptors to glucose dynamics in type 1 diabetes;IFAC Journal of Systems and Control;2024-09

3. Mechanistic Pathways and Clinical Implications of GLP-1 Receptor Agonists in Type 1 Diabetes Management;International Journal of Molecular Sciences;2024-08-29

4. Elevated urinary albumin predicts increased time in range after initiation of SGLT2 inhibitors in individuals with type 1 diabetes on sensor-augmented pump therapy;Diabetology International;2024-08-06

5. Activation of BK channels prevents diabetes-induced osteopenia by regulating mitochondrial Ca ²⁺ and SLC25A5/ANT2-PINK1-PRKN-mediated mitophagy;Autophagy;2024-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3